SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is trending following a $75 million direct offering to a single institutional investor, which fully funds its Phase 3 MASH trial. While the discounted offering has sparked debate over short-term dilution, the community largely views this, coupled with a new $20 Barclays price target and its Breakthrough Therapy Designation, as strategically positioning Altimmune for a potential buyout or partnership of its 'best-in-class' pemvidutide.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending following its recent $2 billion investment in CoreWeave to accelerate AI factory buildouts, which the community views as a strategic move to secure critical infrastructure and future demand, though some debate its immediate necessity. This strategic deepening is complemented by ongoing discussions around potential approvals for H200 chip orders from China, further reinforcing NVIDIA's perceived market leadership in AI despite some observed price action frustration.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending following a sector-wide plunge in health insurance stocks, triggered by a lower-than-expected proposed 2027 Medicare Advantage payment rate increase. The community is sharply divided, with many viewing the sharp decline as an oversold buying opportunity, citing strong fundamentals and anticipating a potential revision to the initial proposal, while others expect ongoing sector pressure, urging caution on recovery and speculating on market manipulation.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares ETF (GLD) is trending due to its parabolic surge, fueled by concerns over dollar debasement, strong central bank accumulation, and geopolitical tensions. The community is actively discussing a significant rotation from digital assets to precious metals, with some anticipating 

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is experiencing significant bullish momentum as gold and silver reach new highs, fueled by widespread discussion of a weakening US dollar and a perceived physical silver shortage. The community is actively debating a potential short squeeze, citing robust industrial demand from AI and EV sectors, alongside a record-breaking streak of retail investor buying.

Fefe is a memecoin inspired by Matt Furie's book "Mindviscosity," published in 2020.  Follow FEFE, the alter ego of PEPE in the book “Mindviscosity” by Matt Furie.  Fefe is a main character in the book, who is a laid back and carefree frog living in a whimsical world. Fefe's relaxed and adventurous spirit captures the heart of this imaginative universe.  Launched stealth with no presale, zero taxes, LP burnt and contract renounced - TAX: 0/0 This narrative has its roots in a fascinating story.  Join us and become part of the $FEFE community today!

Fefe

FEFE CRYPTO is experiencing heightened attention, fueled by its community's active engagement on social platforms and a compelling narrative positioning it as a direct representation of the popular $PEPE meme. Traders are discussing its potential as the 'third frog' alongside $PEPE and $HOPPY, emphasizing its strong community ownership and perceived long-term value within the memecoin space.

Virtuix Holdings Inc. - Ordinary Shares - Class A

Virtuix Holdings Inc. (VTIX) is trending following its recent NASDAQ listing, sparking immense community discussion and highly volatile trading on its debut. Investors are actively debating its potential for further significant price movements, fueled by anticipation from long-term private shareholders and its positioning in the gaming and AI sectors.

Texas Instruments Incorporated engages in the design and manufacture of semiconductors. It operates through the following segments: Analog, Embedded Processing, and Other. The Analog segment semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded processors. The Embedded Processing segment involves handling specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application. The company was founded in 1930 and is headquartered in Dallas, TX.

Texas Instruments Inc.

Texas Instruments is trending following its earnings report, which saw the stock surge in after-hours trading despite missing revenue and EPS estimates. This unexpected positive reaction is largely attributed to the company's strong revenue guidance, signaling an anticipated recovery in analog chip demand and providing a positive signal for the broader semiconductor sector. The community is actively debating how the market reacted so positively to a seemingly mixed report, viewing it as a strong sign for semiconductor prospects.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer (SMCI) is actively debated ahead of its imminent earnings report, fueled by expectations of substantial revenue growth and the absence of a customary pre-earnings warning. Community discussion is polarized, weighing anticipated impressive revenue figures against persistent concerns over margin compression and management's perceived credibility, with a notable short interest adding to market volatility.

Lantronix, Inc. engages in the provision of software as a service (SaaS), engineering services, and hardware for Edge Computing, the Internet of Things (IoT), and Remote Environment Management (REM). Its services include Embedded IoT Solutions, IoT Systems Solutions, and Software and Engineering Services. The company was founded by Bernhard Bruscha in June 1989 and is headquartered in Irvine, CA.

Lantronix Inc

Lantronix (LTRX) is actively discussed due to a notable surge in trading volume and price, driven by its expanding presence in Edge AI and drone technologies. Community sentiment is largely bullish, fueled by strategic partnerships, new product launches at major industry events, and anticipated earnings, all pointing to LTRX's growing traction in defense and industrial IoT markets. Many anticipate further gains and potential short squeezes for the company.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


AVNR
Avanir Pharmaceuticals

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest AVNR News

AVNRAvanir Pharmaceuticals